BSEResult5d ago · 13 Aug 2026, 05:12 pm

Unaudited Financial Results for the quarter ended June 30, 2026.

Deep Health AI India Ltd · 539559

✦ AI SummaryResults

Deep Health AI India Ltd has announced unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 45 lakhs and total income at Rs. 61.61 lakhs. The company has also disclosed its unaudited standalone and consolidated financial results, along with a draft limited review report.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Deep Health AI India Ltd - 539559 - Financial Results For The Quarter Ended June 30, 2026

Attachments (1)

📄

f76cdfc6-7652-4130-ad38-7424e6f119df.pdf

pdf

Download →
View document text
DEEP HEALTH AI INDIA LIMITED (Formerly known as “Deep Diamond India Limited”) CIN: L24100RJ1994PLC112895 Regd. Office: 506-509 fifth floor, Apeksha, Plot No. 256, Main Road, Hiran Magri, Sector 11, Udaipur, Rajasthan (313001) Tel: 0294-3569097. E-mail: deephealthaiindia@gmail.com Website: www.deephealthaiindia.com Date: August 13, 2026 The Manager, BSE Limited Address: Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400001. Scrip Code: 539559 Subject: Submission of Outcome of Board Meeting in compliance with the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”). Dear Sir/Madam, This is to inform you that pursuant to Regulation 30 of the Listing Regulations, the Board at its meeting held today i.e. Thursday, August 13, 2026, inter alia, considered and approved the following: 1. Un-Audited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2026, along with draft Limited Review Report pursuant to Regulation 33 of the Securities Exchange and Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Further, the Trading Window for dealing in shares of the Company has already been closed for all Directors/ KMPs/Designated Employees/ Connected Person of the Company from July 01, 2026, and will remain closed up to 48 (Forty-Eight) hours after the declaration of Un-Audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026 (both days inclusive) in accordance with SEBI (Prohibition of Insider Trading) Regulation, 2015 and the Company’s Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders. The Board Meeting commenced at 3:00 P.M and concluded at 3.40 P.M. Kindly take the same on your records. FOR DEEP HEALTH AI INDIA LIMITED (Formerly known as Deep Diamond India Limited) Narayan Singh Rathore Managing Director DIN: 10900646 Place: Udaipur o/(j{S 'l(&Co. £LP CHARTERED ACCOUNTANTS IND I A 1008, Ajmcra Sikova, Opp. Damodar Park, LBS Marg, Ghatkopar (West) Mumbai -400086 Phone: +91-22-35736454 I Mob: +91-9820572292 I Email: sureshkl8@gmail.com Independent Auditor's Limited Review Report The Board of Directors, Deep Health Al India Limited "We have reviewed the accompanying statement of unaudited quarterly financial results of M/s Deep Health Al India Limited ('the Company'), for the period ended 30th June, 2026 ('the Statement') being submitted by the Company pursuant to the requirement of Regulation 33 of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015. This statement which is the responsibility of the Company's Management and approved by Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Accounting Standard for Interim Financial Reporting (AS 25), prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued there under and other accounting principles generally accepted in India. Our responsibility is to issue a report on the Statement based on our review. We conducted our review in accordance with the standard on Review Engagements (SRE) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Institute of Chartered Accountants of India". This Standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statements are free of material misstatement. A review is limited primarily to inquire of Company personnel and analytical procedures applied to financial data and thus provide less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement is prepared, in all material aspects, in accordance with applicable accounting standards prescribed under Section 133 of the Companies Act, 2013 read with rule 7 of the Companies (Accounts) Rules, 2014 and other recognized accounting practices and policies has not disclosed the information required to be disclosed in terms of regulation 33 of the SEBI (Listing obligations and Disclosure Requirements) Regulations 2015 including the manner in which it is to be disclosed, or that it contains any material misstatement or that it has not been prepared in accordance with the relevant prudential norms issued by Reserve Bank of India in respect of income recognition, asset classification, provisioning and other related matters. For V R S K & CO. LLP {Formerly known as V.R.S.K.& Co.) CHARTERED ACCOUNTANTS Firm~. No: 111426W/W100988 Place Mumbai Suresh G. Kothari Date August 13, 2026 Partner UDIN 2604762STSETNNS409 Membership No: 047625 Page I of l DEEP HEALTH AI INDIA LIMITED Formerly Known as "DEEP DIAMOND INDIA LIMITED" Rcgd. Office: 506-509, fifth floor, Apcksha, Plot No.256, Main Road, llirlln Magri, Sector-11, Udalpur, Rafasthan (313001) CIN: L24100RJ1994PLC1.12895 UNAUDM"ED STA NO ALONE FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH fUNE, 2026 Sr. Particulars ( Rs. in Lakhs) No. Ouarter ended Year ended 30.06.2026 31.03.2026 30.06.2025 31.03.2026 Unaudited Audited Unaudited Audited 1 Revenue from operations -Jewellery Business 45 -.00 25 -.00 15 ..0 0 425.00 -Pharmaceutical Business - 2 Other income 45.00 25.00 15.00 425.00 3 Total income (1 +2} 16.61 18.22 18.68 424.02 61.61 43.22 33.68 849.02 4 Expenses a) Cost of material consumed - - - b) Purchase of Stock-in-Trade - - c) Changes in inventories of finished goods work-in-progress - - - d) a En md p S loto yc ek e - bi en n-T efr ia td s e e xpense - - - - e) Finance costs 4.81 5.89 4.14 18.81 f) Depreciation 0.70 0.73 0.74 2.71 g) Other expenses 0.12 0.13 0.27 0.78 Total expenses 245.88 13.74 16.06 72.64 65 EPr xo cf ei pt/ i( oL no as ls i) eb mef so re exceptional items and tax (3-4) (2 15 81 9. .5 91 22 20 ..4 79 12 21. .2 41 759 44 ..9 04 7 Profit/(Loss) before tax (5-6) - 577.84 . (577.84) 8 Tax expenses : (189.901 (555.11) 12.47 176.24 Current tax-current year - prior year - (103 -.16) 3 -.14 46.33 ProD fie tf /e (r Lre od t )a fx rli ta hb eil pit ey r/ o(a ds s (e 7t -) - - - -- 1111 41 320 BPT BRO ao et sh sst ia ee &&C C m am q iin llupp uudirr usee ri ui revv gpn gn Plto o em lm e se Sf n ha / hg- ( aE a( ev e eC p ae fI a) n fu l tcus e- ee( e ron ) xt o R ln to r 1a ose r/x e f- ) rp ie v te( e9 m+ c1 sh0 ) ,,( 44461 14988 (061999 .... .. 18509 1 3200 2 2 41 ,( , ,( 42 674 2 47 05 (75 61 .. .1. 2 79 50 25 11 1,64 3832 030459 ...... 0554 73 2500 43 ( 61 0 42 02 014 69 ... .. 79 48 21 : 13 (face value of Rs.1/-each) (0.13'. (0.48; 0.02 0.14 * Not annualised, except year end basic and diluted EPS Notes: - 1. T inh ie t sa b mo ev ee t ir ne gs u hl ets ld o of nth 1e 3 C /0o 8m /2p 0a 2n 6y . were reviewed by the Audit Committee and approved by the Board of Directors 2. pF eig ru iore ds / yo ef ath r e p rp er se ev ni to au tis o p ne . riod/year have been regrouped wherever necessary to conform to the current 3. T ish ae p C plo icm ap ba len y to h Ca os mtw po a nb yu .s iness segment, disclosure under Ind AS 108 on "Segment Reporting" issued by the ICAI For Deep Health AI India Limited (Formerly known as Deep Diamond India Limited) Place: Udaipur, Dated; 13th August, 2026 Narayan Singh Rathore Managing Director DIN : 10900646 DEEP HEAL TH AI INDIA LIMITED Fonnerly Known as "DEEP DIAMOND lNDIA LIMITED" Rcgd. OOice: 506-509. lifih Ooor, Apcksha. Plot No.256, Main Road, Hirnn Mogri, Sector-I 1. Udaipur, Rojnsthnn (31300 I) CIN: L24100RJl994PLCI 12895 E-Mail: decphcalthaiindia@gmnil.com Website: www.dccphealthaiindia.com Segment Reporting (Standalone) The Company is responsible for Segment reporting as per lndAS -108 "Operating Segment" specified under section 133 of the Companies Act, 2013. As the Company is engaged in two segments viz. Jewellery of Gold and Diamond S [Showing first 8,000 characters — download PDF for full document]